Pharmexcil appoints Ravi Uday Bhaskar as DG

By Sanjiv Das on January 12, 2017

Ravi Uday Bhaskar, present Addl. Executive Director, Pharmexcil has been appointed as the Director General of the Council with effect from 30.12.2016.

Related Posts

Lupin launches biosimilar Etanercept in Canada

DP World establishes new warehouse in Goa

Naprod renews EU-GMP certification for Palghar facility

Emcure unveils campaign ‘Cure and Beyond’

WHO, THSTI launch e-learning course on rational use of medicines for pharmacists

Bayer secures full ownership of Bayer Zydus Pharma, acquires remaining 25 per cent stakes

Akums introduces DCGI approved FDC medication